Centre for Arctic Health and Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
School of Medicine, Center of Biomedical Research, University of Granada, Granada, Spain.
Environ Health. 2020 Oct 13;19(1):107. doi: 10.1186/s12940-020-00647-1.
Exposure to perfluorinated-alkyl-acids (PFAAs) is ubiquitous. PFAAs are hormone-disrupting compounds that are strongly suspected to affect mother-child-health such as fetal growth. Thyroid disruption is a plausible mechanism of action. We aim to summarize the epidemiological evidence for the relation between prenatal and postnatal exposure to PFAAs and disruption of thyroid homeostasis in mothers and/or infants.
Fifteen original publications on PFAAs concentrations and thyroid hormones (TH) in pregnant women and/or infants were found upon a literature search in the PubMed database. Information on exposure to seven PFAAs congeners [Perfluorooctane sulfonate (PFOS), Perfluorooctanoate (PFOA), Perfluorohexane sulfonate (PFHxS), Perfluorononanoic acid (PFNA), Perfluorodecanoic acid (PFDA), Perfluoroundecanoic acid (PFUnA), and Perfluorododecanoic acid (PFDoA)] and thyroid stimulating hormone (TSH), free and total thyroxine (FT4 and TT4), free and total triiodothyronine (FT3 and TT3), T3RU (Free triiodothyronine resin uptake) and FT4-index (FT4I) levels were recorded. We evaluated sampling of maternal TH by trimester, and infant TH by sex stratification. Reported associations between mother or infant PFAAs and TH were not uniformly assessed in the selected studies.
Ten out of the fifteen studies examined maternal PFAAs concentration and TSH level. Seven studies showed significant associations between TSH and exposure to six PFAAs congeners, most of them were positive. Maternal T4 and T3 were investigated in nine studies and five studies found inverse associations between exposure to six PFAAs congeners and TH (TT3, TT4, FT3, FT4 and FT4I) levels. Eight of the fifteen studies investigated PFAAs concentrations and infant TSH. Infant TSH level was significantly affected in four studies, positively in three studies. Nine studies investigated infant T4 and T3 and seven studies found significant associations with PFAAs exposure. However, both inverse and positive significant associations with infant TH were found eliciting no clear direction.
Results indicate a mainly positive relationship between maternal PFAAs concentrations and TSH levels, and suggestion of an inverse association with T4 and/or T3 levels. Associations of infant TH with PFAAs concentration were less consistent.
全氟烷基酸(PFAAs)的暴露是普遍存在的。PFAAs 是一种具有激素干扰作用的化合物,强烈怀疑它们会影响母婴健康,如胎儿生长。甲状腺干扰是一种合理的作用机制。我们旨在总结产前和产后暴露于 PFAAs 与母亲和/或婴儿甲状腺内稳态紊乱之间关系的流行病学证据。
通过在 PubMed 数据库中进行文献检索,共发现 15 篇关于孕妇和/或婴儿中 PFAAs 浓度和甲状腺激素(TH)的原始出版物。记录了 7 种 PFAAs 同系物[全氟辛烷磺酸(PFOS)、全氟辛酸(PFOA)、全氟己烷磺酸(PFHxS)、全氟壬酸(PFNA)、全氟癸酸(PFDA)、全氟十一烷酸(PFUnA)和全氟十二烷酸(PFDoA)]和促甲状腺激素(TSH)、游离和总甲状腺素(FT4 和 TT4)、游离和总三碘甲状腺原氨酸(FT3 和 TT3)、T3RU(游离三碘甲状腺原氨酸树脂摄取)和 FT4I(FT4I)水平的信息。我们评估了按妊娠月份取样的母亲 TH 和按性别分层的婴儿 TH。所选研究中并未统一评估母亲或婴儿 PFAAs 与 TH 之间的关联。
在 15 项研究中,有 10 项研究检查了母亲 PFAAs 浓度和 TSH 水平。有 7 项研究表明 TSH 与六种 PFAAs 同系物的暴露之间存在显著关联,其中大多数为阳性。有 9 项研究调查了母亲 T4 和 T3,有 5 项研究发现六种 PFAAs 同系物的暴露与 TH(TT3、TT4、FT3、FT4 和 FT4I)水平之间存在反比关系。有 15 项研究中的 8 项调查了 PFAAs 浓度和婴儿 TSH。有 4 项研究表明婴儿 TSH 水平受到显著影响,其中 3 项研究为阳性。有 9 项研究调查了婴儿 T4 和 T3,有 7 项研究发现与 PFAAs 暴露存在显著关联。然而,婴儿 TH 与 PFAAs 暴露之间既有正向关联也有反向关联,没有明确的方向。
结果表明,母亲 PFAAs 浓度与 TSH 水平之间主要呈正相关,与 T4 和/或 T3 水平呈负相关的可能性。婴儿 TH 与 PFAAs 浓度的关联则不太一致。